Medicines Distribution Consent




720 NEW ZEALAND GAZETTE, No. 30 27 JANUARY 2005

Product: Foban
Active Ingredient: Fusidic acid 2%w/w
Dosage Form: Topical cream
New Zealand Sponsor: AFT Pharmaceuticals Limited
Manufacturers: Hoe Pharmaceuticals Sdn. Bhd., Bandar Sultan Suleiman, Pelabuhan Klang, Selangor, Malaysia

Product: Lipobase Lipocort
Active Ingredient: Hydrocortisone 10mg/g
Dosage Form: Topical cream
New Zealand Sponsor: CSL New Zealand Limited
Manufacturer: Yamanouchi Europe BV, Meppel, The Netherlands

Product: Poly Gel
Active Ingredient: Carbomer 0.3%w/w
Dosage Form: Ophthalmic gel
New Zealand Sponsor: Pacific Pharmaceuticals Limited
Manufacturer: Laboratoires Alcon S.A., Ferrenbach, Kaysersberg, France

Dated this 20th day of January 2005.

BARRY BORMAN, acting as Deputy Director-General, Public Health, for the period 5 January 2005 to 24 January 2005
(pursuant to delegation given by the Minister of Health on 6 July 2001).

go468

Consent to the Distribution of Changed Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:

Schedule

Product: AmBisome
Active Ingredient: Amphotericin B 50mg
Dosage Form: Powder for injection
New Zealand Sponsor: Gilead Sciences (NZ)
Manufacturers: Gilead Sciences Inc, Covina Boulevard, San Dimas, California, United States of America
Gilead Sciences Inc, Cliffside Drive, San Dimas, California, United States of America

Product: ReFacto
Active Ingredient: Moroctocog alfa 1,000IU equivalent to 90 µg
Dosage Form: Powder for injection
New Zealand Sponsor: Wyeth (NZ) Ltd
Manufacturers: Octapharma AB, Stockholm, Sweden
Wyeth Farma S.A., San Sebastian de los Reyes, Madrid, Spain

Product: ReFacto
Active Ingredient: Moroctocog alfa 250IU equivalent to 23µg
Dosage Form: Powder for injection
New Zealand Sponsor: Wyeth (NZ) Ltd
Manufacturers: Octapharma AB, Stockholm, Sweden
Wyeth Farma S.A., San Sebastian de los Reyes, Madrid, Spain

Product: ReFacto
Active Ingredient: Moroctocog alfa 500IU equivalent to 45µg
Dosage Form: Powder for injection
New Zealand Sponsor: Wyeth (NZ) Ltd
Manufacturers: Octapharma AB, Stockholm, Sweden
Wyeth Farma S.A., San Sebastian de los Reyes, Madrid, Spain

Dated this 20th day of January 2005.

BARRY BORMAN, acting as Deputy Director-General, Public Health, for the period 5 January 2005 to 24 January 2005
(pursuant to delegation given by the Minister of Health on 6 July 2001).

go469



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2005, No 30


Gazette.govt.nz PDF NZ Gazette 2005, No 30





✨ LLM interpretation of page content

🏥 Consent to Distribution of New Medicine Foban

🏥 Health & Social Welfare
20 January 2005
Medicines, Consent, Distribution, Foban, Fusidic acid, Topical cream, AFT Pharmaceuticals
  • BARRY BORMAN, acting as Deputy Director-General, Public Health

🏥 Consent to Distribution of New Medicine Lipobase Lipocort

🏥 Health & Social Welfare
20 January 2005
Medicines, Consent, Distribution, Lipobase Lipocort, Hydrocortisone, Topical cream, CSL New Zealand
  • BARRY BORMAN, acting as Deputy Director-General, Public Health

🏥 Consent to Distribution of New Medicine Poly Gel

🏥 Health & Social Welfare
20 January 2005
Medicines, Consent, Distribution, Poly Gel, Carbomer, Ophthalmic gel, Pacific Pharmaceuticals
  • BARRY BORMAN, acting as Deputy Director-General, Public Health

🏥 Consent to Distribution of Changed Medicines

🏥 Health & Social Welfare
20 January 2005
Medicines, Consent, Distribution, AmBisome, ReFacto, Amphotericin B, Moroctocog alfa, Powder for injection
  • BARRY BORMAN, acting as Deputy Director-General, Public Health